無菌調剤薬局の世界市場レポート 2024

無菌調剤薬局の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.0%の年間複合成長率（CAGR）で67億米ドルに成長すると予想されます。予測期間中に予想される成長は、慢性疾患の増加、人口の高齢化、ヘルスケアニーズの増大、医薬品不足とサプライチェーンの混乱への懸念、精密医療の進歩、患者中心への注目の高まりなどの要因に起因すると考えられます。予測期間中に予想される主な動向には、オートメーションとロボット工学の統合、厳格な規制遵守への重点、個別化医療と特殊な化合物の重視、調合サービスのアウトソーシングへの移行、無菌技術の技術進歩などが含まれます。

個別化医療に対する需要の急増が予想され、将来の無菌調剤薬局市場の成長を促進する態勢が整っています。個人の遺伝子やタンパク質に関する情報を利用して病気を予防、診断、治療する個別化医療は、無菌調剤薬局によって促進されます。これらの薬局は、無菌環境で個別化された医薬品を提供し、個人のニーズに基づいて医薬品を調整して、治療結果、患者の満足度、治療遵守を向上させる上で重要な役割を果たしています。特に、個別化医療連合が報告したように、2022年に12の新たな個別化医療が承認されたことは、個別化医療の重要性が高まっていることを浮き彫りにしています。したがって、個別化医療に対する需要の高まりが、無菌調剤薬局市場の成長の原動力となっています。

高齢化人口の急増は、無菌調剤薬局市場の成長に大きく貢献しています。社会における高齢者の割合の増加を特徴とする高齢化社会では、カスタマイズされた医薬品ソリューションを提供する無菌調剤薬局の恩恵を受けることができます。これらの薬局では、液剤、局所剤、座薬などのさまざまな剤形の薬を用意しており、高齢者がより使いやすくなっています。世界保健機関の2022年10月のデータによると、世界の60歳以上の人口は2020年の10億人から2030年には14億人に増加すると予想されており、高齢化人口の拡大が無菌調剤薬局市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の無菌調剤薬局市場促進要因と制約要因
  • 市場の促進要因
  • 市場の抑制要因
• 世界の無菌調剤薬局の市場規模実績と成長、2018～2023年
• 世界の無菌調剤薬局市場規模と成長予測、2023年から2028年、2033年

第6章 市場セグメンテーション

• 世界の無菌調剤薬局市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 注射剤
• 鼻
• 眼
• 耳
• 世界の無菌調剤薬局市場、治療領域別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ホルモン補充療法
• 疼痛管理
• 皮膚科
• 腫瘍学
• 血液学
• 歯科
• その他の治療領域
• 世界の無菌調剤薬局市場、投与経路別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 静脈内
• 筋肉内
• 皮下
• 世界の無菌調剤薬局市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 大人
• 小児科
• 老人医学
• 獣医

第7章 地域および国の分析

• 世界の無菌調剤薬局市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の無菌調剤薬局市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 無菌調剤薬局市場の競合情勢
• 無菌調剤薬局市場の企業プロファイル
  • B. Braun SE
  • PharMerica Corporation
  • Fagron Group BV
  • QuVa Pharma Inc.
  • NewCo Pharma GmbH

第31章 その他の大手および革新的な企業

• Medisca
• PharMEDium Healthcare Holdings Inc.
• Central Admixture Pharmacy Services（CAPS）
• SandsRx LLC
• LeeSar Inc.
• Avella Specialty Pharmacy
• Stokes Pharmacy Inc.
• Imprimis Pharmaceuticals Inc.
• Wells Pharmacy Network LLC
• McGuff Compounding Pharmacy Services Inc.
• Potter's House Apothecary Inc.
• Pharos Innovations LLC
• Triangle Compounding Pharmacy Inc.
• Valor Compounding Pharmacy Inc.
• Pace Pharmacy

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Sterile compounding pharmacies are specialized facilities that prepare personalized medications in a sterile environment, tailoring medication to the specific needs of individuals. This approach proves beneficial for various reasons, including patient intolerance to standard commercial doses or specific components. Compounding in a sterile environment enables patients to receive drugs with customized doses and formulations, excluding non-essential and undesirable components.

The primary products in sterile compounding pharmacies include injectables, nasal, ocular, and otic formulations. Injectables are pharmacological substances or drugs intended for injection into the body using a needle and syringe. Sterile compounding pharmacies offer production services such as customization, patient-specific dosing, and elimination of intolerable components, ensuring the safety, sterility, and quality of injectable medications tailored to individual patient requirements. These injectables find application in various therapeutic areas, including hormone replacement therapy, pain management, dermatology, oncology, hematology, dental, among others. Administration routes include intravenous, intramuscular, and subcutaneous, catering to diverse end-users such as adults, pediatrics, geriatrics, and veterinary applications.

The sterile compounding pharmacies market research report is one of a series of new reports from The Business Research Company that provides sterile compounding pharmacies market statistics, including sterile compounding pharmacies industry global market size, regional shares, competitors with a sterile compounding pharmacies market share, detailed sterile compounding pharmacies market segments, market trends and opportunities, and any further data you may need to thrive in the sterile compounding pharmacies industry. This sterile compounding pharmacies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sterile compounding pharmacies market size has grown strongly in recent years. It will grow from $4.99 billion in 2023 to $5.3 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth observed during the historical period can be attributed to factors such as concerns about patient safety, a shift towards personalized medicine, the increasing adoption of home infusion therapies, the involvement of sterile compounding pharmacies in clinical trials and investigational drugs, and the support for rare diseases.

The sterile compounding pharmacies market size is expected to see strong growth in the next few years. It will grow to $6.7 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated growth in the forecast period can be attributed to factors such as the rise in chronic diseases, the aging population and increasing healthcare needs, concerns about drug shortages and supply chain disruptions, advancements in precision medicine, and an increased focus on patient-centric care. Major trends expected in the forecast period include the integration of automation and robotics, a focus on stringent regulatory compliance, the emphasis on personalized medicine and specialized compounds, a shift towards outsourced compounding services, and technological advances in aseptic techniques.

The anticipated surge in the demand for personalized medicine is poised to propel the growth of the sterile compounding pharmacies market in the future. Personalized medicine, which utilizes information about an individual's genes or proteins to prevent, diagnose, or treat diseases, is facilitated by sterile compounding pharmacies. These pharmacies play a crucial role in delivering personalized medications in a sterile environment, tailoring drugs based on individual needs to enhance treatment outcomes, patient satisfaction, and therapy adherence. Notably, the approval of 12 new personalized medicines in 2022, as reported by the Personalized Medicine Coalition, underscores the increasing prominence of personalized medicine. Hence, the escalating demand for personalized medicine is a driving force behind the growth of the sterile compounding pharmacies market.

The burgeoning aging population significantly contributes to the growth of the sterile compounding pharmacies market. An aging population, characterized by an increasing proportion of older individuals within a society, benefits from sterile compounding pharmacies that provide customized medication solutions. These pharmacies prepare medications in various forms, such as liquid, topical, or suppository, making them more accessible for the aging population. According to October 2022 data from the World Health Organization, the global population aged 60 or above is expected to grow from 1 billion in 2020 to 1.4 billion in 2030. Thus, the expanding aging population is a driving factor for the growth of the sterile compounding pharmacies market.

The adoption of robotic automation emerges as a prominent trend in the sterile compounding pharmacies market. Major companies in the market focus on leveraging robotic automation to enhance their market position. For example, in March 2023, Omnicell Inc., a healthcare technology company, introduced the IVX Station, a robotic compounding technology designed for safe and efficient sterile compounding preparations using automation. This technology features an automated compounding process in an ISO Class 5 environment, incorporating continuous monitoring of temperature, humidity, and particles. The IVX Station prioritizes safety with advanced vision systems, gravimetric verification, auto-labeling, and automated application of tamper-evident syringe caps. Moreover, it offers scalability through a cloud-based formulation library, ensuring access to the latest authorized formulations for manufacturers.

Major companies in the sterile compounding pharmacies market adopt strategic acquisition and collaboration as part of their growth strategy. A strategic acquisition involves one company purchasing another or its assets to achieve long-term strategic objectives. In October 2023, Sharp, a pharmaceutical packaging company, acquired Berkshire Sterile Manufacturing (BSM) to enhance its capabilities in offering fully integrated small-to-medium scale sterile injectable services. The acquisition complements Sharp's services with BSM's expertise in sterile manufacturing and Contract Development and Manufacturing Organization (CDMO) services.

In January 2022, Revelation Pharma Corp, a compounding pharmacy company, acquired Innovation Compounding Inc. for an undisclosed amount. This strategic acquisition aligns with Revelation's goal of establishing a national network of 503A and 503B compounding pharmacies. Innovation Compounding Inc., a 503A compounding pharmacy, provides sterile and non-sterile compounded pharmaceuticals to patients in 49 states.

Major companies operating in the sterile compounding pharmacies market report are B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., Absolute Pharmacy Inc.

North America was the dominant region in the sterile compounding pharmacies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sterile compounding pharmacies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sterile compounding pharmacies market consists of sales of injectable drugs and infusions created in an environment free from microorganisms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sterile Compounding Pharmacies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sterile compounding pharmacies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sterile compounding pharmacies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sterile compounding pharmacies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Injectables; Nasal; Ocular; Otic
• 2) By Therapeutic Area: Hormone Replacement Therapy; Pain Management; Dermatology; Oncology; Hematology; Dental; Other Therapeutic Areas
• 3) By Route of Administrations: Intravenous; Intramuscular; Subcutaneous
• 4) By End-Users: Adults; Pediatrics; Geriatrics; Veterinary
• Companies Mentioned: B. Braun SE; PharMerica Corporation; Fagron Group BV; QuVa Pharma Inc.; NewCo Pharma GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sterile Compounding Pharmacies Market Characteristics

3. Sterile Compounding Pharmacies Market Trends And Strategies

4. Sterile Compounding Pharmacies Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Sterile Compounding Pharmacies Market Size and Growth

• 5.1. Global Sterile Compounding Pharmacies Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Sterile Compounding Pharmacies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Sterile Compounding Pharmacies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sterile Compounding Pharmacies Market Segmentation

• 6.1. Global Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Injectables
• Nasal
• Ocular
• Otic
• 6.2. Global Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hormone Replacement Therapy
• Pain Management
• Dermatology
• Oncology
• Hematology
• Dental
• Other Therapeutic Areas
• 6.3. Global Sterile Compounding Pharmacies Market, Segmentation By Route of Administrations, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Intravenous
• Intramuscular
• Subcutaneous
• 6.4. Global Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Adults
• Pediatrics
• Geriatrics
• Veterinary

7. Sterile Compounding Pharmacies Market Regional And Country Analysis

• 7.1. Global Sterile Compounding Pharmacies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Sterile Compounding Pharmacies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sterile Compounding Pharmacies Market

• 8.1. Asia-Pacific Sterile Compounding Pharmacies Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sterile Compounding Pharmacies Market

• 9.1. China Sterile Compounding Pharmacies Market Overview
• 9.2. China Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sterile Compounding Pharmacies Market

• 10.1. India Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sterile Compounding Pharmacies Market

• 11.1. Japan Sterile Compounding Pharmacies Market Overview
• 11.2. Japan Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sterile Compounding Pharmacies Market

• 12.1. Australia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sterile Compounding Pharmacies Market

• 13.1. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sterile Compounding Pharmacies Market

• 14.1. South Korea Sterile Compounding Pharmacies Market Overview
• 14.2. South Korea Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sterile Compounding Pharmacies Market

• 15.1. Western Europe Sterile Compounding Pharmacies Market Overview
• 15.2. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sterile Compounding Pharmacies Market

• 16.1. UK Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sterile Compounding Pharmacies Market

• 17.1. Germany Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sterile Compounding Pharmacies Market

• 18.1. France Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sterile Compounding Pharmacies Market

• 19.1. Italy Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sterile Compounding Pharmacies Market

• 20.1. Spain Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sterile Compounding Pharmacies Market

• 21.1. Eastern Europe Sterile Compounding Pharmacies Market Overview
• 21.2. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sterile Compounding Pharmacies Market

• 22.1. Russia Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sterile Compounding Pharmacies Market

• 23.1. North America Sterile Compounding Pharmacies Market Overview
• 23.2. North America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sterile Compounding Pharmacies Market

• 24.1. USA Sterile Compounding Pharmacies Market Overview
• 24.2. USA Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sterile Compounding Pharmacies Market

• 25.1. Canada Sterile Compounding Pharmacies Market Overview
• 25.2. Canada Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sterile Compounding Pharmacies Market

• 26.1. South America Sterile Compounding Pharmacies Market Overview
• 26.2. South America Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sterile Compounding Pharmacies Market

• 27.1. Brazil Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sterile Compounding Pharmacies Market

• 28.1. Middle East Sterile Compounding Pharmacies Market Overview
• 28.2. Middle East Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sterile Compounding Pharmacies Market

• 29.1. Africa Sterile Compounding Pharmacies Market Overview
• 29.2. Africa Sterile Compounding Pharmacies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Sterile Compounding Pharmacies Market, Segmentation By Therapeutic Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Sterile Compounding Pharmacies Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sterile Compounding Pharmacies Market Competitive Landscape And Company Profiles

• 30.1. Sterile Compounding Pharmacies Market Competitive Landscape
• 30.2. Sterile Compounding Pharmacies Market Company Profiles
  • 30.2.1. B. Braun SE
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. PharMerica Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Fagron Group BV
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. QuVa Pharma Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. NewCo Pharma GmbH
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Sterile Compounding Pharmacies Market Other Major And Innovative Companies

• 31.1. Medisca
• 31.2. PharMEDium Healthcare Holdings Inc.
• 31.3. Central Admixture Pharmacy Services (CAPS)
• 31.4. SandsRx LLC
• 31.5. LeeSar Inc.
• 31.6. Avella Specialty Pharmacy
• 31.7. Stokes Pharmacy Inc.
• 31.8. Imprimis Pharmaceuticals Inc.
• 31.9. Wells Pharmacy Network LLC
• 31.10. McGuff Compounding Pharmacy Services Inc.
• 31.11. Potter's House Apothecary Inc.
• 31.12. Pharos Innovations LLC
• 31.13. Triangle Compounding Pharmacy Inc.
• 31.14. Valor Compounding Pharmacy Inc.
• 31.15. Pace Pharmacy

32. Global Sterile Compounding Pharmacies Market Competitive Benchmarking

33. Global Sterile Compounding Pharmacies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sterile Compounding Pharmacies Market

35. Sterile Compounding Pharmacies Market Future Outlook and Potential Analysis

• 35.1 Sterile Compounding Pharmacies Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Sterile Compounding Pharmacies Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Sterile Compounding Pharmacies Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer